Serotonergic modulation of the P300 event related brain potential

Human Psychopharmacology

Volumn 13, Issue 4, 1998, Pages 239-243

  Hansenne, Michel ^a   Pitchot, William ^a   Papart, Patrick ^a   Ansseau, Marc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cognition; Flesinoxan test; Neurobiology; P300; Serotonin

Indexed keywords

FLESINOXAN; PROLACTIN; SEROTONIN 1 AGONIST;

ADULT; ARTICLE; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REACTION TIME; SEROTONINERGIC NERVE CELL;

EID: 0031831021     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199806)13:4<239::AID-HUP986>3.0.CO;2-V     Document Type: Article

References (30)

1. Buhot, M. C. (1997). Serotonin receptors in cognitive behaviors. Current Opinion in Neurobiology, 7, 243-254.
2. Cassel, J. C. and Jeltsch, H. (1995). Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience, 69, 1-41.
3. Coccaro, E. F., Gabriel, S. and Siever, L. J. (1990). Buspirone challenge: preliminary evidence for a role for central 5-HT1A receptor function in impulsive aggressive behavior in human. Psychopharmacological Bulletin, 26, 393-405.
4. Coccaro, E., Siever, L. S., Klar, H. M., Maurer, G., Cochran, K., Cooper, T. B., Mohs, R. C. and Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry, 46, 587-599.
5. Donchin, E. and Coles, M. H. G. (1988). Is the P300 component a manifestation of context updating? Brain and Behavioral Science, 11, 357-374.
6. Groenink, L. and Olivier, B. (1998). Neuroendocrine effects induced by 5-HT1A receptor agonists are mediated centrally, via postsynaptic 5-HT1A receptors. Brain Research, in press.
7. Hammond, E. J., Meador, K. J., Aung-Din, R. and Wilder, B. K. (1987). Role of the cholinergic system in the generation of human cognitive evoked potentials. Neurology, 37, 346-350.
8. Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Timsit-Berthier, M. and Ansseau, M. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology, 96, 194-196.
9. Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Reggers, J., Machurot, P.-Y. and Ansseau, M. (1997). Harm avoidance dimension of the tridimensional personality questionnaire and serotonin-1A activity in depressed patients. Biological Psychiatry, 42, 659-661.
10. Harder, J. A., Maclean, C. J., Alder, J. T., Francis, P. T. and Ridley, R. M. (1996). The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology, 127, 245-254.
11. Hasbroucq, T., Rihet, P., Blin, O. and Possamai, C. A. (1997). Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neuroscience Letters, 229, 204-208.
12. Ito, J., Yamoa, S., Fukuda, H., Mimori, Y. and Nakamura, S. (1990). The P300 event-related potentials in dementia of the Alzheimer type. Correlations between P300 and monoamine metabolites. Electroencephalography and Clinical Neurophysiology, 77, 174-178.
13. Johnson, R., Jr. (1986). A triarchic model of P300 amplitude. Psychophysiology, 23, 367-384.
14. Johnson, R., Jr. (1993). On the neural generators of the P300 component of the event-related potential. Psychophysiology, 30, 90-97.
15. Jonkman, L. M., Kemmer, C., Vertaben, M. N., Koelega, H. S., Camfferman, G., Van der Gaag, R-J., Buitelaar, J. K. and Van Engeland, H. (1997). Effects of methylphenidate on event-related potentials and performance of attention-deficit hyperactivity disorder children in auditory and visual selective attention tasks. Biological Psychiatry, 41, 690-702.
16. Kutas, M., McCarthy, G. and Donchin, E. (1977). Augmenting mental chronometry: the P300 as a measure of stimulus evaluation time. Science, 197, 792-795.
17. McCarthy, G. and Donchin, E. (1981). A metric for thought: a comparison of P300 latency and reaction time. Science, 211, 77-80.
18. Meador, K. J. (1995). Cholinergic, serotonergic, and gabaergic effects on the ERP. In Karmos, G., Molnár, M., Csépe, V., Czigler, I. and Desmedt, J. E. (Eds), Perspectives of event-related potentials research, Electroencephalography and Clinical Neurophysiology, Suppl. 44, 151-155.
19. Meador, K. J., Loring, D. W., Davis, H. C., Setli, K. D., Patel, B. R. and Adams, R. J. (1989). Cholinergic and serotonergic effects on P3 potential and recent memory. Journal of Clinical and Experimental Neuropsychology, 11, 252-260.
20. New, A. S., Tresman, R. L., Mitropoulou, V., Benishay, D. S., Coccaro, E. F., Silverman, J. and Siever, L. J. (1997). Serotonin function and self-injurious behavior in personality disorder patients. Psychiatry Research, 69, 17-26.
21. Picton, T. W. (1992). The P300 wave of the human event-related potential. Journal of Clinical Neurophysiology, 9, 456-479.
22. Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Lembreghts, M., Hansenne, M., Wauthy, J., Reel, C., Jammaer, R., Papart, P., Sulon, J. and Legros, J-J. (1995). The flesinoxan 5-HT1A receptor challenge test in major depression and suicidal behavior. Pharmacopsychiatry, 28, 91-92.
23. Polich, J. (1991). P300 in the evaluation of aging and dementia. In Brunia, C. H. M., Mulder, G. and Vertaben, M. N. (Eds), Event-related brain research, Electroencepholagraphy and Clinical Neurophysiology, Suppl. 42, 304-323.
24. Pritchard, W. S., Raz, N. and August, G. J. (1986). Brief report: No effect of chronic fenfluramine on the P300 component of the event-related potential. International Journal of Neuroscience, 35, 105-110.
25. Raine, A. and Venables, P. H. (1988). Enhanced P3 evoked potentials and longer recovery times in psychopaths. Psychophysiology, 25, 30-38.
26. Semlitsch, H. V., Anderer, P. and Saletu, B. (1995). Acute effects of the anxiolytics suriclone and alprazolam on cognitive processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects. European Journal of Clinical Pharmacology, 49, 183-191.
27. Smulders, F. T. Y., Kok, A., Kenemans, J. L. and Bashore, T. R. (1995). The temporal selectivity of additive factor effects on the reaction process revealed in ERP component latencies. Acta Psychologica, 90, 97-109.
28. Sommer, W. and Matt, J. (1990). Awareness of P300-related cognitive processes: a signal detection approach. Psychophysiology, 27, 575-585.
29. Swick, D., Pineda, A. and Foote, S. L. (1994). Effects of systematic clonidine on auditory event-related potentials in squirrel monkeys. Brain Research Bulletin, 33, 79-86.
30. Verleger, R. (1988). Event-related potentials and cognition: a critique of the context updating hypothesis and an alternative interpretation of P3. Behavioral and Brain Sciences, 11, 343-356.